GenHealth.ai, a health‑tech startup focused on automating healthcare administration, announced on Tuesday that it closed a $16.5 million Series A financing round.
Launched in 2023, the company serves medical practices with AI agents that manage back‑office functions such as patient intake, eligibility checks, prior authorizations, billing, denial management and appeals. GenHealth emerged as a spin‑out from 1upHealth, a firm specializing in health‑data interoperability.
“Healthcare providers and suppliers often need to hire large teams just to collect money they’ve already earned,” said Ricky Sahu, CEO of GenHealth, in an email. “The workload is so heavy that staff become overburdened and struggle to devote sufficient attention to reviewing hundreds of pages of charts, verifying eligibility across multiple portals, and pursuing low‑value denials. Our AI agents work alongside existing staff and current record‑keeping systems to autonomously handle these time‑consuming tasks.”
Flare Capital Partners led the Series A round, with participation from Craft, Obvious Ventures, Eniac Ventures, InHealth Ventures, Epsilon Health Investors and ARTIS. To date, GenHealth has raised a total of $30 million.
Flare Capital Partners says GenHealth addresses a significant unmet need. “Customers describe GenHealth as transparent and highly configurable—qualities that competing products often lack,” noted Victor Lanio, partner at Flare, and Alyssa Tsenter, senior associate at Flare, in a blog post. “One operator told us the team ‘knows what they are doing,’ a stark contrast to other solutions they had tried, and praised how quickly the platform understood and automated their workflows. Another client, who had abandoned a legacy system after more than two years of frustration, said they finally feel at ease.”
The proceeds will fund customer acquisition and further development of the technology so the AI can “automatically learn and build customer workflows passively,” Sahu explained.
In the United States, healthcare administration accounts for roughly $1 trillion in annual spending. GenHealth’s long‑term objective is to automate this substantial administrative burden, according to Sahu.
“With today’s AI advances, the majority of that work is poised for automation,” he said. “Achieving that requires a novel approach that is both accurate and cost‑effective within healthcare. GenHealth is developing AI‑based methods that are nearly deterministic, avoiding the overhead, expense and variability associated with image‑based computer models.”
He added that GenHealth customers are experiencing revenue growth of up to 34% and administrative‑cost reductions of as much as 80%.
Photo: Topp_Yimgrimm, Getty Images
Also Read
- A Trauma Clinic in Birmingham Offers Healing to Asylum Seekers Bearing Deep Scars
- STAT+: Alloy Therapeutics Names Venkat Krishnamurthy as CSO for Genetic Medicines
- The Reality Behind Weight-Loss Jabs: Examining the Science on Side Effects from Hair Loss to ‘Ozempic Breath’
- Nighttime Light Exposure Linked to Harmful Remodeling of the Heart, Study Finds


